Key result
Surgical repair of congenital mitral valve dysplasia resulted in 93% actuarial survival and 89% freedom from reintervention at 20 years.
Why the study?
What are the long-term survival and reintervention rates following surgical repair of congenital mitral valve dysplasia?
Cohort (n=100)
No
What are the long-term survival and reintervention rates following surgical repair of congenital mitral valve dysplasia?
Surgical repair of congenital mitral valve dysplasia provides excellent long-term survival (93% at 20 years), though nearly one-fifth of patients eventually require reintervention.
Answers are grounded in this paper and cite their sources.
Supports surgical repair feasibility in congenital mitral dysplasia; leaves open need for contemporary validation.
BACKGROUND AND AIM OF THE STUDY: Congenital mitral valve (MV) dysplasia is a relatively rare and highly complex cardiac disease. We present our results and illustrate the techniques used to repair these valves. METHODS: Between 1972 and 2014, 100 consecutive patients underwent surgical repair of congenital MV dysplasia at our institution. Predominant MV regurgitation was present in 53 patients (53%) whereas mitral stenosis was prevalent in 47 (47%). RESULTS: There were five early (5%) and eight late deaths (9%). Actuarial survival was 95%, 94%, and 93% at 5, 10, and 20 years, respectively. Sixteen patients (18%) required reintervention due to subsequent MV dysfunction. Actuarial freedom from reintervention for MV dysfunction was 95%, 92%, and 89% at 5, 10, and 20 years, respectively. CONCLUSIONS: The mechanism underlying the valve dysfunction in congenital mitral valve dysplasia is multifactorial and requires the application of a variety of surgical techniques for repair. doi: 10.1111/jocs.12743 (J Card Surg 2016;31:352-356).
No takes yet. Share an insight, caveat, or question.
Vida et al. (2016) conducted a cohort in Congenital mitral valve dysplasia (n=100). Surgical repair was evaluated on Actuarial survival at 20 years. Surgical repair of congenital mitral valve dysplasia resulted in 93% actuarial survival and 89% freedom from reintervention at 20 years.
Synapse has enriched 10 related papers. Consider them for comparative context: